Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo

Detalles Bibliográficos
Autores principales: Shi, Fei, Zhang, Jinying, liu, Hongyu, Wu, Liangliang, Jiang, Hongyu, Wu, Qiyan, Liu, Tianyi, Lou, Meiqing, Wu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908321/
https://www.ncbi.nlm.nih.gov/pubmed/29683149
http://dx.doi.org/10.18632/oncotarget.25063
_version_ 1783315701629452288
author Shi, Fei
Zhang, Jinying
liu, Hongyu
Wu, Liangliang
Jiang, Hongyu
Wu, Qiyan
Liu, Tianyi
Lou, Meiqing
Wu, Hao
author_facet Shi, Fei
Zhang, Jinying
liu, Hongyu
Wu, Liangliang
Jiang, Hongyu
Wu, Qiyan
Liu, Tianyi
Lou, Meiqing
Wu, Hao
author_sort Shi, Fei
collection PubMed
description
format Online
Article
Text
id pubmed-5908321
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-59083212018-04-20 Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo Shi, Fei Zhang, Jinying liu, Hongyu Wu, Liangliang Jiang, Hongyu Wu, Qiyan Liu, Tianyi Lou, Meiqing Wu, Hao Oncotarget Correction Impact Journals LLC 2018-03-30 /pmc/articles/PMC5908321/ /pubmed/29683149 http://dx.doi.org/10.18632/oncotarget.25063 Text en Copyright: © 2018 Shi et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Correction
Shi, Fei
Zhang, Jinying
liu, Hongyu
Wu, Liangliang
Jiang, Hongyu
Wu, Qiyan
Liu, Tianyi
Lou, Meiqing
Wu, Hao
Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
title Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
title_full Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
title_fullStr Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
title_full_unstemmed Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
title_short Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
title_sort correction: the dual pi3k/mtor inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908321/
https://www.ncbi.nlm.nih.gov/pubmed/29683149
http://dx.doi.org/10.18632/oncotarget.25063
work_keys_str_mv AT shifei correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT zhangjinying correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT liuhongyu correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT wuliangliang correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT jianghongyu correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT wuqiyan correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT liutianyi correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT loumeiqing correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo
AT wuhao correctionthedualpi3kmtorinhibitordactolisibelicitsantitumoractivityinvitroandinvivo

Ejemplares similares